Skip to content

Attentional Focus and Prefrontal Cortical Activation in Older Adults and Patients With Parkinson's Disease (PD)

Effects of Different Attentional Focus During Walking on Prefrontal Cortical Activation in Older Adults and Patients With Parkinson's Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05073874
Acronym
AttPark
Enrollment
45
Registered
2021-10-12
Start date
2021-12-08
Completion date
2024-05-08
Last updated
2024-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Keywords

Attention, NIRS, Gait, Prefrontal cortex, Parkinson's disease

Brief summary

Attention may influence the motor performance and frontal activity. This study will examine the effect of different attentional focus: internal, external and divided attention (dual task) on prefrontal cortical activation (fNIRS) and on gait performance. Thirty older adults and thirty PD will participate in this study.

Detailed description

The subjects will be guided to walk at a normal pace while maintaining the required attentional focus. Subjects will walk on 20 m four times in each of the four different focus conditions : 1. no instructions about the attentional focus 2. internal focus on their feet movements, 3. external focus on two lines drawn on the floor, 4. divided attention (walking while performing an arithmetic task). A fNIRS system will be used for the prefrontal cortex activation evaluation and FeetMe soles for gait analyses.

Interventions

The hemodynamic response in prefrontal cortex will be measured using an Octomon+ system (Artinis). Eight emission and two detector probes will be arranged on the participant's forehead.

Sponsors

Centre Hospitalier Régional d'Orléans
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
60 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* For 2 groups : * Man or woman 60-85 years old * Informed consent obtained * Group Parkinson : clinical diagnosis of idiopathic Parkinson's Disease, according to the UK Brain Bank criteria.

Exclusion criteria

* For 2 groups : * Assisted walker * Neurological (other than those resulting from Parkinson's disease), cardiologic, rheumatologic disorders * Disorders affecting gait. * Montreal Cognitive Assessment (MOCA) \< 24. * Concomitant medication likely to interfere with the results. * Group Parkinson: * freezing * Hoehn et Yahr \> III

Design outcomes

Primary

MeasureTime frameDescription
Effects of oxyhemoglobin variations on hemodynamic response in prefrontal cortexBaselineOxyhemoglobin variations in prefrontal cortex will be measured with a fNIRS system, on a 20 meters distance.
Effects of deoxyhemoglobin variations on hemodynamic response in prefrontal cortexBaselineDeoxyhemoglobin variations in prefrontal cortex will be measured with a fNIRS system

Secondary

MeasureTime frameDescription
Effects of speed on gait.baselineGait parameters will be measured with connected soles FeetMe ® : speed
Effects of cadence on gait.baselineGait parameters will be measured with connected soles FeetMe ® : cadence
Effects of stride length on gait.baselineGait parameters will be measured with connected soles FeetMe ® : stride length
Effects of double support time on gait.baselineGait parameters will be measured with connected soles FeetMe ® : double support time.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026